21
Jun

2012

Successful week for GliaCure at the 2012 BIO International Convention

GliaCure’s participation in the 2012 BIO International Convention in Boston was very successful. The booth included a triptych backdrop with the central banner asking, “Are You GliaCurious?” Looping iPad presentations attracted attention and resultant traffic at the booth was great. President Phil Haydon and VP Mike Szulczewski were busy with in-booth meetings with representatives from…more »

17
Jun

2012

GliaCure gets ready for 2012 BIO International Convention

GliaCure is preparing for the 2012 BIO International Convention that runs from Monday, June 18 through Thursday, June 21 in the Boston Convention & Exhibition Center in the Boston Innovation District. GliaCure has set up its booth at the Convention Center and will be participating in more than 20 partnering meetings. Check back for pictures…more »

07
Jun

2012

New publication supports GliaCure’s findings

On May 10, 2012 an article by was published by a research group in the journal Cerebral Cortex. This paper details a study in human brain tissue showing that bidirectional signaling takes place between neurons and astrocytes. Cerebral Cortex is not an open access journal, so the full report is available only to subscribers; however,…more »

15
May

2012

New federal funding to support the fight against Alzheimer’s disease

On May 15, 2012 Health and Human Services Secretary Kathleen Sebelius announced new funding initiatives to aid in the fight against Alzheimer’s disease. The plan, presented at the Alzheimer’s Research Summit 2012, includes funding of new research projects, tools for clinicians, easier access to information for caregivers and an awareness campaign.

26
Apr

2012

GliaCure to participate in 2012 BIO International Convention

GliaCure will be participating in the 2012 BIO International Convention, June 18-21 at the Boston Convention & Exhibition Center, MA. Owners Phil Haydon and Mike Szulczewski will be available to meet with company representatives interested in GliaCure’s research and drug development and to discuss potential partnering opportunities.

10
Apr

2012

Walter E. Dewey, C.F.A.

Walter Dewey received his B.B.A. in Finance in 1983 from the University of Wisconsin-Madison.  He is Vice President and Portfolio Manager at Madison Investment Advisors, specializing in investment and wealth management services for families and individuals with high net worth.  Prior to joining Madison Investment Advisors in 2013, he spent 5 years at Reinhart Partners…more »

10
Apr

2012

Michael Szulczewski, B.S.E.E.

GliaCure Vice President Michael Szulczewski received his BSEE with a major option in integrated circuits and electron devices in 1981 from the University of Wisconsin – Madison. Mike was also the President and co-Founder of Prairie Technologies, Inc. Based in Madison, Wisconsin, Prairie manufactures, sells and supports laser microscopy instruments worldwide for use in cell…more »

09
Apr

2012

Philip G. Haydon, Ph.D.

Philip Haydon is President of GliaCure and the Annetta and Gustav Grisard Professor and Chair in the Department of Neuroscience at Tufts. In 1994 Phil Haydon’s laboratory discovered that astrocytes can release the chemical transmitter glutamate in response to receptor-induced Ca2+ elevations and that this glial-mediated signal can activate neighboring neurons. Since then his studies…more »

Page 5 of 6